💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

U.S. shares ease with Fed, earnings awaited this week

Published 01/30/2017, 03:32 PM
Updated 01/30/2017, 03:33 PM
© Reuters.  U.S. shares weaker
US500
-
DJI
-
MSFT
-
MRK
-
GOOGL
-
AAPL
-
AMZN
-
SBUX
-
PFE
-
IXIC
-
META
-
GOOG
-

Investing.com - Shares eased in the U.S. on Monday with the market turning attention to the latest monetary policy views from the Federal Reserve and more quarterly earnings this week with e-commerce, social media and pharmacy in focus.

The Dow Jones fell 0.87%, the S&P 500 dipped 0.86%, while the Nasdaq Composite eased 1.02%.

Overnight, sentiment was bruised after Trump on Friday suspended travel to the United States from Syria, Iraq, Iran and four other Muslim-majority countries, saying the moves would help protect Americans from terrorist attacks.

The executive order led to huge protests in many U.S. cities and sparked global backlash, raising worries about the potentially destabilizing impact of Trump's policies.

Several U.S. tech companies such as Google (NASDAQ:NASDAQ:GOOGL), Apple (NASDAQ:NASDAQ:AAPL) and Microsoft (NASDAQ:NASDAQ:MSFT) have criticized the ban, while Starbucks (NASDAQ:NASDAQ:SBUX) chief executive Howard Schultz promised that the company would hire 10,000 refugees globally.

In economic news, data out Monday was mixed while personal spending continued to rise in December in line with expectations, but personal income advancing slightly less than expected.

The core PCE price index, a preferred gauge of inflation for the Federal Reserve (Fed), measured an annual rise of 1.7% in December, in line with expectations and the prior month’s upwardly revised reading.

In the real estate market, pending home sales once again showed strength in December with a 1.6% rise that beat expectations for a 1.1% increase.

In any case, market participants were also taking positions ahead of the Fed’s policy decision announcement on Wednesday or the jobs report on Friday.

Investors will also continue to focus on earnings as tech giants Apple (NASDAQ:AAPL), Facebook (NASDAQ:NASDAQ:FB) and Amazon (NASDAQ:NASDAQ:AMZN) as well as major drug companies Merck (NYSE:NYSE:MRK) and Pfizer (NYSE:NYSE:PFE) will release this week.

With 107 out of 500 S&P firms already having reported fourth quarter earnings, The Earnings Scout warned that despite a 67% beat rate on profit, only 25% of those companies had first quarter estimates raised with the average settling at a decline of 0.88% so far.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.